Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction
暂无分享,去创建一个
R. Wilkinson | E. Sturrock | B. Mayosi | M. Ntsekhe | K. Wilkinson | K. Matthews | M. Badri | Janine Wolske
[1] P. Collinson,et al. Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial , 2011, Heart.
[2] Y. Adler,et al. Risk of Constrictive Pericarditis After Acute Pericarditis , 2011, Circulation.
[3] A. Jaffe. The 10 commandments of troponin, with special reference to high sensitivity assays , 2011, Heart.
[4] S. Perlini,et al. Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. , 2010, Clinical science.
[5] O. Carretero,et al. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. , 2009, American journal of physiology. Heart and circulatory physiology.
[6] J. Iredale,et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. , 2008, The American journal of pathology.
[7] M. Cavasin,et al. Decreased Endogenous Levels of Ac-SDKP Promote Organ Fibrosis , 2007, Hypertension.
[8] P. Collinson,et al. Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study. , 2012, Clinical chemistry.